Pharmacyclics sponsored the study. Dr. Wang disclosed consulting, having equity ownership in, and receiving research funding from, Pharmacyclics. He also disclosed relationships with Celgene, Millennium, Novartis, and Onyx. Dr. Smith disclosed board membership and receiving research funding from Cephalon, and being on the speakers bureau for Celgene, Genentech, Spectrum, and Allos.
News
Mantle Cell Lymphoma: BTK Inhibitor Scores Again
